Casey Woodring
Stock Analyst at JP Morgan
(0.63)
# 3,793
Out of 4,740 analysts
28
Total ratings
27.78%
Success rate
-16.2%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $71.19 | +32.04% | 5 | Nov 5, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $375 → $280 | $203.07 | +37.88% | 4 | Oct 25, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | $270 → $205 | $168.22 | +21.86% | 5 | Aug 8, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $52 → $54 | $47.25 | +14.29% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.89 | +54.24% | 3 | May 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $44.48 | -16.82% | 3 | Feb 14, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $24.58 | -6.43% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $13.60 | +32.35% | 2 | Jan 23, 2023 |
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $71.19
Upside: +32.04%
ICON Public Limited Company
Oct 25, 2024
Maintains: Overweight
Price Target: $375 → $280
Current: $203.07
Upside: +37.88%
Charles River Laboratories International
Aug 8, 2024
Downgrades: Neutral
Price Target: $270 → $205
Current: $168.22
Upside: +21.86%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $47.25
Upside: +14.29%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.89
Upside: +54.24%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $44.48
Upside: -16.82%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $24.58
Upside: -6.43%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $13.60
Upside: +32.35%